Long-Term Liabilities: The sum of all non-current liabilities.
Regencell Bioscience Holdings Limited (RGC) had Long-Term Liabilities of $0.13M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.36M |
|
$0.18M |
|
$0.66M |
|
$3.01M |
|
$1.67M |
|
-- |
|
|
Long-Term Liabilities |
$0.13M |
$1.79M |
|
$1.22M |
|
$1.22M |
|
$1.22M |
|
494.49M |
|
| Cash Flow Statement Financials | |
$-2.59M |
|
$2.50M |
|
-- |
|
$2.42M |
|
$2.36M |
|
$-0.06M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|